Home
Scholarly Works
Efficacy and Safety of Upadacitinib in Patients...
Conference

Efficacy and Safety of Upadacitinib in Patients with Giant Cell Arteritis (SELECT-GCA): A Double-Blind, Randomized Controlled Phase 3 Trial

Authors

Merkel P; Penn S; Setty A; Schmidt W; Rubbert-Roth A; Hauge EM; Keen H; Ishii T; Khalidi N; Meng L

Volume

76

Pagination

pp. 1607-1610

Publisher

WILEY

Publication Date

September 1, 2024

Conference proceedings

ARTHRITIS & RHEUMATOLOGY

ISSN

2326-5191

Contact the Experts team